Your session is about to expire
← Back to Search
Behavioural Intervention
Financial Incentives for Smoking Cessation
N/A
Waitlist Available
Led By Christi Patten, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months, 12 months
Awards & highlights
Study Summary
This trialwill evaluate a smoking cessation program tailored to Alaska Native families to see if it works.
Who is the study for?
This trial is for Alaska Native and American Indian adults who smoke, live in Alaska, and want to quit. They must have smoked at least 3 cigarettes daily over the past 3 months and have a family member willing to join them. Participants need access to a mobile device with internet; if not, they'll be provided an iPad mini. Those already using stop-smoking programs or pharmacotherapy recently cannot join.Check my eligibility
What is being tested?
The study tests whether financial rewards and written support materials help families quit smoking together. It's culturally tailored for Alaska Natives, checking if incentives plus support can boost success rates compared to usual methods.See study design
What are the potential side effects?
There are no direct medical side effects from participating as this trial involves non-medical interventions like financial incentives and educational materials rather than drugs or medical procedures.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months, 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months, 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in smoking status
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Incentives intervention conditionExperimental Treatment2 Interventions
Subjects will receive generic, existing resources and referral information on evidence-based tobacco/nicotine cessation treatment services including the Alaska quitline, regional Tribal cessation programs, and smokefree.gov services and Alaska Native Tribal Health Consortium (ANTHC) family wellness resources on general health topics (e.g., injury prevention, household air quality) that include regional links to programs for domestic violence. Subjects will additionally receive individual cash card rewards for achieving biochemically verified smoking abstinence at each time point.
Group II: No incentives control conditionActive Control1 Intervention
Subjects will receive generic, existing resources and referral information on evidence-based tobacco/nicotine cessation treatment services including the Alaska quitline, regional Tribal cessation programs, and smokefree.gov services and ANTHC family wellness resources on general health topics (e.g., injury prevention, household air quality) that include regional links to programs for domestic violence.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,205 Previous Clinical Trials
3,766,726 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,464 Previous Clinical Trials
2,618,535 Total Patients Enrolled
Christi Patten, PhDPrincipal InvestigatorMayo Clinic
3 Previous Clinical Trials
160 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not smoke marijuana weekly or am willing to quit for the study.I haven't used any quit-smoking drugs or programs in the last 3 months.I am a family member participant and I am 18 years old or older.I am 18 years old or older.I am a family member of any gender and from any racial or ethnic group.I am considering or willing to try quitting.
Research Study Groups:
This trial has the following groups:- Group 1: Incentives intervention condition
- Group 2: No incentives control condition
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Has recruitment commenced for this trial?
"Affirmative. Clinicaltrials.gov reports that this study, initially posted on November 1st 2022, is currently recruiting patients. At the current time, 36 people are needed from 1 medical site."
Answered by AI
What is the total enrollment scope of this investigation?
"Affirmative. Clinicaltrials.gov lists this investigation as actively recruiting participants, with the initial post dated November 1st 2022 and a recent update on November 8th of that same year. 36 patients are being sought from one medical centre for inclusion in the study."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger